{"product_id":"brodys-human-pharmacology-mechanism-based-therapeutics-paperback-9780323476522","title":"Brody's Human Pharmacology; Mechanism-Based Therapeutics (Paperback \/ softback) 9780323476522","description":"\u003cfont face=\"Georgia\"\u003e\r\n\u003cp\u003e\u003cfont size=\"6\"\u003eBrody's Human Pharmacology\u003c\/font\u003e\u003cbr\u003e\r\n\u003cfont size=\"5\"\u003eMechanism-Based Therapeutics\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cem\u003e\u003cp\u003eBuild a strong foundation in both the fundamental and clinical aspects of pharmacology\u003c\/p\u003e\u003c\/em\u003e\u003c\/p\u003e\r\n\r\n\r\n\u003cp\u003e\u003cfont size=\"4\"\u003eLynn Wecker (Edited by), Lynn Wecker (Author)\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003e9780323476522, Elsevier Health Sciences\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003ePaperback \/ softback, published 3 August 2018\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003e728 pages, 450 illustrations (450 in full color)\u003cbr\u003e27.6 x 21.6 x 4.4 cm, 1.81 kg\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\r\n\r\n\r\n\r\n\u003cp align=\"justify\"\u003e\u003cstrong\u003e\u003cfont size=\"3\"\u003e\u003cp\u003eFocusing on \u003cb\u003ethe essential aspects of pharmacology you need to know\u003c\/b\u003e, \u003ci\u003eBrody‘s Human Pharmacology, 6th Edition\u003c\/i\u003e, keeps you fully up to date with all that’s new in the field. \u003cb\u003eStreamlined content, a new organizational approach, enhanced online components, and thoroughly updated information\u003c\/b\u003e ensure your grasp of key concepts and prepare you for exams. Nearly 500 full-color illustrations explain important processes, while color-coded boxes for major drugs, therapeutic overviews, clinical problems, and trade names reinforce your mastery of the information.\u003c\/p\u003e\n\u003cp\u003e\u003cb\u003eThe 6th Edition of this easy-to-use text is now fully up to date with:\u003c\/b\u003e\u003c\/p\u003e  \u003cul\u003e  \u003cp\u003e \u003c\/p\u003e\n\u003cli\u003e\n\u003cb\u003eNEW chapter\u003c\/b\u003e devoted entirely to \u003cb\u003epharmacogenomics\u003c\/b\u003e and \u003cb\u003epersonalized medicine\u003c\/b\u003e.\u003c\/li\u003e \u003cli\u003e\n\u003cb\u003eNEW\u003c\/b\u003e \u003cb\u003echapter\u003c\/b\u003e on \u003cb\u003ecannabinoids\u003c\/b\u003e and their use for pain and other disorders, in light of recent legalization in many states.\u003c\/li\u003e \u003cli\u003e\n\u003cb\u003eNEW\u003c\/b\u003e \u003cb\u003echapters\u003c\/b\u003e on recent developments in the treatment of \u003cb\u003eAlzheimer's disease, ADHD\u003c\/b\u003e and the latest treatments for \u003cb\u003eHIV\u003c\/b\u003e.\u003c\/li\u003e \u003cli\u003e\n\u003cb\u003eNEW\u003c\/b\u003e \u003cb\u003esection\u003c\/b\u003e on \u003cb\u003epain management.\u003c\/b\u003e  \u003c\/li\u003e\n\u003cli\u003e\n\u003cb\u003eNEW section \u003c\/b\u003ein each chapter covering \"Clinical Relevance for Healthcare Professionals\" that provides important information specific to physical therapists, dentists and dental hygienists, and many other medical professionals.\u003c\/li\u003e\n\u003c\/ul\u003e \u003cb\u003e\u003ci\u003e  \u003c\/i\u003e\u003c\/b\u003e\u003cp\u003ePlus these student-friendly features:\u003c\/p\u003e  \u003cul\u003e  \u003cp\u003e \u003c\/p\u003e\n\u003cli\u003eA new organizational approach, focusing on integration and systems-based learning.\u003c\/li\u003e \u003cli\u003e\n\u003cb\u003eContributions from leading faculty\u003c\/b\u003e who cover the most important aspects of pharmacology necessary for a basic understanding of the subject, including concepts, clinical applications, and side effects.\u003c\/li\u003e \u003cli\u003e\n\u003cb\u003eUSMLE-style self-assessment questions\u003c\/b\u003e at the end of every chapter, answers and rationales in the Appendix.\u003c\/li\u003e \u003cli\u003e\n\u003cb\u003eOnline access to Student Consult\u003c\/b\u003e?where you’ll find the complete contents of the book, fully searchable...150 USMLE-style questions...and more.\u003c\/li\u003e\n\u003c\/ul\u003e\u003c\/font\u003e\u003c\/strong\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003e\u003cp\u003eSection 1 Mechanisms of Drug Action and Therapeutic Principles\u003c\/p\u003e \u003cp\u003e1. Introduction, Terminology\u003c\/p\u003e \u003cp\u003e2. Pharmacodynamics: Drug Targets (Receptors, Enzymes, DNA, etc)\u003c\/p\u003e \u003cp\u003e3. Pharmacokinetics\u003c\/p\u003e \u003cp\u003e4. Pharmacogenomics\u003c\/p\u003e \u003cp\u003e5. Drug Discovery, Development, and Regulation\u003c\/p\u003e \u003cp\u003eSection 2 Chemical Mediators and Drugs Affecting Autonomic and Neuromuscular Synapses\u003c\/p\u003e \u003cp\u003e6. Introduction to the Peripheral Nervous Systems and Drugs for Peripheral Disorders\u003c\/p\u003e \u003cp\u003eCholinergic Drugs\u003c\/p\u003e \u003cp\u003e7. Muscarinic Agonists and Their Clinical Uses\u003c\/p\u003e \u003cp\u003e8. Muscarinic Antagonists and Their Clinical Uses\u003c\/p\u003e \u003cp\u003e9. Nicotinic Agonists and Their Clinical Uses\u003c\/p\u003e \u003cp\u003e10. Nicotinic Antagonists and Neuromuscular Blocking Drugs\u003c\/p\u003e \u003cp\u003eAdrenergic Drugs\u003c\/p\u003e \u003cp\u003e11. Adrenergic Agonists and Their Clinical Uses\u003c\/p\u003e \u003cp\u003e12. Adrenergic Antagonists and Their Clinical Uses\u003c\/p\u003e \u003cp\u003eSection 3 Drug Treatment for Disorders Affecting the Central Nervous System\u003c\/p\u003e \u003cp\u003e13. Introduction to the CNS and Drugs Affecting the Brain\u003c\/p\u003e \u003cp\u003eNeurodegenerative Disorders\u003c\/p\u003e \u003cp\u003e14. Drug Therapy for Alzheimer's Disease and Other Cognitive Disorders\/Dementias\u003c\/p\u003e \u003cp\u003e15. Pharmacotherapy of Basal Ganglia Disorders: Parkinson's Disease and Huntington's Disease\u003c\/p\u003e \u003cp\u003e16. Drug Therapy for Psychoses and Bipolar Disorder\u003c\/p\u003e \u003cp\u003e17. Drug Therapy for Depression and Anxiety\u003c\/p\u003e \u003cp\u003e18. Drug Therapy for the Management of Attention Deficit Hyperactivity Disorder\u003c\/p\u003e \u003cp\u003e19. Drug Therapy for Insomnia and the Hypersomnias\u003c\/p\u003e \u003cp\u003e20. Drug Therapy for Managing Obesity and Eating Disorders\u003c\/p\u003e \u003cp\u003e21. Treatment of Seizure Disorders\u003c\/p\u003e \u003cp\u003e22. Drug Therapy to Control Spasticity Disorders\u003c\/p\u003e \u003cp\u003e23. Ethanol, Other Alcohols, and Drugs for Alcohol Use Disorder\u003c\/p\u003e \u003cp\u003e24. Illicit Psychoactive Compounds and Substance Use Disorder\u003c\/p\u003e \u003cp\u003eSection 4 Drug Therapy for Pain Management\u003c\/p\u003e \u003cp\u003e25. Introduction\u003c\/p\u003e \u003cp\u003e26. General Anesthetics\u003c\/p\u003e \u003cp\u003e27. Local Anesthetics\u003c\/p\u003e \u003cp\u003e28. Opioid Analgesics\u003c\/p\u003e \u003cp\u003e29. Nonsteroidal Anti-inflammatory Agents and Acetaminophen\u003c\/p\u003e \u003cp\u003e30. Cannabinoids\u003c\/p\u003e \u003cp\u003eSection 5 Treatment of Inflammatory, Allergic and Immunologic Disorders\u003c\/p\u003e \u003cp\u003e31. Drug Therapy for Migraine Headache \u003c\/p\u003e \u003cp\u003e32. Drug Therapy for Gout and Hyperuricemia\u003c\/p\u003e \u003cp\u003e33. Drug Treatment for Allergic Reactions\u003c\/p\u003e \u003cp\u003e34. Immunosuppressants for Autoimmune Disorders and Organ Transplantation\u003c\/p\u003e \u003cp\u003e35. Drug Therapy for Rheumatoid Arthritis\u003c\/p\u003e \u003cp\u003eSection 6 Drug Treatment for Cardiovascular Diseases\u003c\/p\u003e \u003cp\u003e36. Introduction to The Cardiovascular System and the Regulation of Blood Pressure and Heart Rate\u003c\/p\u003e \u003cp\u003e37. Overview of Hypertension Management and Drugs that Decrease Sympathetic Tone\u003c\/p\u003e \u003cp\u003e38. Diuretics and Drugs that Affect Volume and Electrolyte Content\u003c\/p\u003e \u003cp\u003e39. Drugs Affecting the Renin-Angiotensin-Aldosterone System\u003c\/p\u003e \u003cp\u003e40. Calcium Channel Blockers\u003c\/p\u003e \u003cp\u003e41. Vasodilators\u003c\/p\u003e \u003cp\u003e42. Drug Therapy for Hyperlipidemias and Atherosclerotic Cardiovascular Disease\u003c\/p\u003e \u003cp\u003e43. Drug Therapy for Myocardial Ischemia and Angina Pectoris\u003c\/p\u003e \u003cp\u003e44. Treatment of Heart Failure: Cardiac Glycosides, Phosphodiesterase Inhibitors and Other Agents\u003c\/p\u003e \u003cp\u003e45. Antiarrhythmic Drugs\u003c\/p\u003e \u003cp\u003e46. Anticoagulant, Antiplatelet and Thrombolytic Agents\u003c\/p\u003e \u003cp\u003e47. Drug Therapy for Hemophilia and the Anemias\u003c\/p\u003e \u003cp\u003eSection 7 Treatment of Endocrine Disorders\u003c\/p\u003e \u003cp\u003e48. Introduction to Endocrine Pharmacology\u003c\/p\u003e \u003cp\u003e49. Treatment of Hypothalamic and Pituitary Disorders\u003c\/p\u003e \u003cp\u003e50. Treatment of Adrenalcorticosteroid Disorders\u003c\/p\u003e \u003cp\u003e51. Female Hormone Regulation\u003c\/p\u003e \u003cp\u003e52. Androgens, antiandrogens and their clinical uses\u003c\/p\u003e \u003cp\u003e53. Drug Therapy for the Management of Diabetes\u003c\/p\u003e \u003cp\u003e54. Drug Therapy for the Management of Thyroid Disorders\u003c\/p\u003e \u003cp\u003e55. Calcium Regulating Hormones and Agents Affecting Bone\u003c\/p\u003e \u003cp\u003eSection 8 Chemotherapy\u003c\/p\u003e \u003cp\u003eInfectious Diseases\u003c\/p\u003e \u003cp\u003e56. Principles of Antimicrobial Use\u003c\/p\u003e \u003cp\u003e57. Bacterial Cell Wall Synthesis Inhibitors\u003c\/p\u003e \u003cp\u003e58. Inhibitors of Protein Synthesis\u003c\/p\u003e \u003cp\u003e59. Drugs that Target DNA\u003c\/p\u003e \u003cp\u003e60. Antimycobacterial Drugs and the Treatment of Tuberculosis and Leprosy\u003c\/p\u003e \u003cp\u003e61. Drug Therapy for Resistant Organisms\u003c\/p\u003e \u003cp\u003eParasitic Diseases\u003c\/p\u003e \u003cp\u003e62. Antifungal Agents\u003c\/p\u003e \u003cp\u003e63. Antimalarial and Other Antiprotozoal Agents\u003c\/p\u003e \u003cp\u003e64. Antihelmintics\u003c\/p\u003e \u003cp\u003eViruses\u003c\/p\u003e \u003cp\u003e65. Drug Therapy for non-HIV Viral Infections\u003c\/p\u003e \u003cp\u003e66. Drugs for HIV and Related Opportunistic Infections\u003c\/p\u003e \u003cp\u003eCancer\u003c\/p\u003e \u003cp\u003e67. Introduction and Therapeutic Principles\u003c\/p\u003e \u003cp\u003e68. Cytotoxic Agents\u003c\/p\u003e \u003cp\u003e69. Targeted Agents\u003c\/p\u003e \u003cp\u003eSection 9 Special Considerations\u003c\/p\u003e \u003cp\u003e70. Therapeutic Use of Hematopoietic Growth Factors, Vitamins and Minerals\u003c\/p\u003e \u003cp\u003e71. Gastrointestinal Disorders and Their Treatment\u003c\/p\u003e \u003cp\u003e72. Pharmacological Treatment of Asthma and COPD \u003c\/p\u003e \u003cp\u003e73. The Role of Neutraceuticals and Natural Products\u003c\/p\u003e \u003cp\u003e74. Essentials of Toxicology\u003c\/p\u003e \u003cp\u003e75. Therapeutic Considerations for Pregnant, Pediatric, Geriatric and Obese Individuals \u003c\/p\u003e\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003eSubject Areas: Pharmacology [\u003ca title=\"See our other books on Pharmacology\" href=\"https:\/\/freshlyprintedbooks.co.uk\/search?q=%22Pharmacology%20%5BMMG%5D%22\"\u003eMMG\u003c\/a\u003e]\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\r\n\u003c\/font\u003e","brand":"Elsevier","offers":[{"title":"Default Title","offer_id":46648216912152,"sku":"9780323476522","price":44.79,"currency_code":"GBP","in_stock":false}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0730\/2037\/5320\/products\/9780323476522_6d87bea0-20a2-4fc4-a7e7-6d42e08ebc63.jpg?v=1694989831","url":"https:\/\/freshlyprintedbooks.co.uk\/products\/brodys-human-pharmacology-mechanism-based-therapeutics-paperback-9780323476522","provider":"Freshly Printed Books","version":"1.0","type":"link"}